RxHub Triggers Antitrust Complaints From NCPA; FTC Sounds Interested
Executive Summary
The Federal Trade Commission may look into the Internet-based patient drug benefit exchange RxHub in response to complaints from retail pharmacy that the business is anticompetitive.